News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
295,812 Results
Type
Article (14373)
Company Profile (110)
Press Release (281329)
Section
Business (97388)
Career Advice (473)
Deals (17433)
Drug Delivery (64)
Drug Development (39873)
Employer Resources (49)
FDA (7051)
Job Trends (6553)
News (166138)
Policy (15466)
Tag
Academia (495)
Alliances (26598)
Alzheimer's disease (423)
Approvals (7060)
Artificial intelligence (69)
Bankruptcy (145)
Best Places to Work (4647)
Biotechnology (46)
Breast cancer (67)
Cancer (469)
Career advice (415)
Cell therapy (67)
Clinical research (33247)
Collaboration (212)
Compensation (81)
COVID-19 (853)
C-suite (60)
Data (486)
Diabetes (70)
Diagnostics (1713)
Drug discovery (45)
Drug pricing (59)
Earnings (35161)
Events (40796)
Executive appointments (225)
FDA (7322)
Funding (149)
Gene therapy (69)
GLP-1 (311)
Government (1397)
Healthcare (4155)
Infectious disease (875)
Inflammatory bowel disease (54)
Interviews (58)
IPO (6696)
Job creations (2130)
Job search strategy (381)
Layoffs (171)
Legal (3766)
Lung cancer (64)
Manufacturing (122)
Medical device (2233)
Medtech (2236)
Mergers & acquisitions (10828)
Metabolic disorders (207)
Neuroscience (544)
NextGen Class of 2024 (1694)
Non-profit (629)
Northern California (537)
Obesity (118)
Opinion (112)
Patents (66)
People (30447)
Pharmaceutical (67)
Phase I (8821)
Phase II (14164)
Phase III (12416)
Pipeline (220)
Policy (46)
Postmarket research (1447)
Preclinical (3531)
Radiopharmaceuticals (127)
Rare diseases (115)
Real estate (2900)
Regulatory (10918)
Research institute (601)
Resumes & cover letters (55)
Southern California (538)
Startups (1846)
United States (5303)
Vaccines (129)
Weight loss (82)
Date
Today (62)
Last 7 days (261)
Last 30 days (935)
Last 365 days (14095)
2024 (14028)
2023 (16103)
2022 (22809)
2021 (23387)
2020 (21942)
2019 (16694)
2018 (13074)
2017 (15481)
2016 (14665)
2015 (17287)
2014 (13944)
2013 (11980)
2012 (12922)
2011 (13405)
2010 (12134)
Location
Africa (339)
Arizona (44)
Asia (30582)
Australia (3957)
California (1266)
Canada (748)
China (184)
Colorado (47)
Connecticut (53)
Europe (45044)
Florida (187)
Illinois (142)
Indiana (96)
Japan (65)
Kansas (56)
Maryland (220)
Massachusetts (1073)
Minnesota (83)
New Jersey (545)
New York (377)
North Carolina (316)
Northern California (537)
Pennsylvania (334)
South America (550)
Southern California (538)
Texas (166)
Virginia (46)
Washington State (81)
295,812 Results for "torrent pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Press Releases
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
December 3, 2024
·
15 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Press Releases
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
October 15, 2024
·
4 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
Press Releases
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 3, 2024
·
8 min read
Press Releases
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
September 26, 2024
·
3 min read
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
October 15, 2024
·
3 min read
1 of 29,582
Next
